Heather Uribe, APRN CNM in Chaska, MN - Advanced Practice Midwife

Heather Uribe, APRN CNM is a Advanced Practice Midwife based in Chaska, Minnesota. Heather Uribe is licensed to practice in Minnesota (license number 555) and her current practice location is 1580 White Oak Dr, Chaska, Minnesota. She can be reached at her office (for appointments etc.) via phone at (952) 856-0071.

NPI number for Heather Uribe is 1457130049 and her current mailing address is 1580 White Oak Dr, Chaska, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1457130049.

Contact Information

	Heather Uribe, APRN CNM
	1580 White Oak Dr, Chaska, MN 55318-2919
	(952) 856-0071
	Not Available

Provider's Profile

Full Name	Heather Uribe
Gender	Female
Speciality	Advanced Practice Midwife
Location	1580 White Oak Dr, Chaska, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1457130049
Provider Enumeration Date: 09/25/2023
Last Update Date: 10/22/2023

Medical Identifiers

Medical identifiers for Heather Uribe such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457130049	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	555 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Heather Uribe is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Heather Uribe, APRN CNM 1580 White Oak Dr, Chaska, MN 55318-2919 Ph: (952) 856-0071	Heather Uribe, APRN CNM 1580 White Oak Dr, Chaska, MN 55318-2919 Ph: (952) 856-0071

News Archive

MJFF announces acquisition of parkin research tools from Imago Pharmaceuticals

The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.

Research looks at protective effects of acupuncture against NSAID-induced ulceration in a rat model

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used as anti-inflammatory and analgesic agents.

First time mothers and their infants could benefit from induction of labor at 41 weeks

There is growing evidence that pregnant women who go beyond term, especially first time mothers and their infants, will benefit from induction of labour at 41 weeks, instead of expectant management with subsequent induction of labour at 42 weeks if labour will not start spontaneously.

ALEC congratulates Pennsylvania legislators for filing House Bills to protect the right of individuals

The American Legislative Exchange Council (ALEC) - the nation's largest nonpartisan individual membership association of state legislators - congratulates Pennsylvania State Representatives Matthew Baker and Curt Schroder for filing House Bills 2053 and 2179, which protect the right of individuals to make their own health care choices.

Nanoscale dots target and track apoptosis

Apoptosis, or programmed cell death, is a hallmark effect triggered by effective anticancer drugs. Now, researchers in Korea have developed a biocompatible, fluorescent nanoparticle that could provide an early sign that apoptosis is occurring as a result of anticancer therapy.

Heather Uribe, APRN CNM - Advanced Practice Midwife in Chaska, MN